Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase-4 inhibitors and sulphonylureas: a primary care database analysis
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase-4 inhibitors and sulphonylureas: a primary care database analysis
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume 15, Issue 1, Pages 55-61
Publisher
Wiley
Online
2012-08-04
DOI
10.1111/j.1463-1326.2012.01674.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Meta-Analysis of Effect of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Risk in Type 2 Diabetes Mellitus
- (2012) Harshal R. Patil et al. AMERICAN JOURNAL OF CARDIOLOGY
- Impact of Hypoglycemia Associated With Antihyperglycemic Medications on Vascular Risks in Veterans With Type 2 Diabetes
- (2012) Y. Zhao et al. DIABETES CARE
- The risk of overall mortality in patients with Type 2 diabetes receiving different combinations of sulfonylureas and metformin: a retrospective analysis
- (2012) K. M. Pantalone et al. DIABETIC MEDICINE
- Medication Adherence in Type 2 Diabetes: The ENTRED Study 2007, a French Population-Based Study
- (2012) Michel Tiv et al. PLoS One
- Comparisons of Persistence and Durability Among Three Oral Antidiabetic Therapies Using Electronic Prescription-Fill Data: The Impact of Adherence Requirements and Stockpiling
- (2011) R A Greevy et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Tolerability of Dipeptidyl Peptidase-4 Inhibitors: A Review
- (2011) Kathleen R. Richard et al. CLINICAL THERAPEUTICS
- DPP-4 Inhibitors: Impact on glycemic control and cardiovascular risk factors
- (2011) D. Dicker DIABETES CARE
- Behandlung des Diabetes mellitus Typ 2
- (2011) S. Matthaei et al. Diabetologie und Stoffwechsel
- Hypoglycaemia: current management and controversies
- (2011) P. Choudhary et al. POSTGRADUATE MEDICAL JOURNAL
- The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy: A retrospective analysis
- (2010) K. M. Pantalone et al. DIABETES CARE
- An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials
- (2010) M. Ligueros-Saylan et al. DIABETES OBESITY & METABOLISM
- Effect of Noninsulin Antidiabetic Drugs Added to Metformin Therapy on Glycemic Control, Weight Gain, and Hypoglycemia in Type 2 Diabetes
- (2010) Olivia J. Phung JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Persistence Patterns with Oral Antidiabetes Drug Treatment in Newly Treated Patients—A Population-Based Study
- (2010) Jean-Pierre Grégoire et al. VALUE IN HEALTH
- Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors
- (2009) Manfredi Rizzo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started